01
Hair cloning in 2026: clinical and preclinical development status
Cell-based rejuvenation has entered early human studies. Dependable creation of new follicles remains preclinical.
7 min read →Research library
Research reports and technical explainers
This library covers the science, clinical development and practical implications of hair-follicle regeneration. Each article distinguishes developer statements from independently established evidence.
02
Three technologies described as “hair cloning”
Rejuvenation, multiplication and de novo regeneration have different biological objectives and evidence requirements.
5 min read →03
Evaluating claims in hair-regeneration research
An evidence framework for distinguishing experimental findings from clinically available treatments.
6 min read →04
Dermal papilla cells in hair-follicle regeneration
The instructive cells at the base of the follicle are central to several programs, but their behaviour can change in culture.
5 min read →05
Regulatory development of a cell-based hair treatment
Clinical efficacy is only one part of the road: manufacturing, sterility, identity and long-term safety are equally decisive.
6 min read →06
Five development indicators for 2026–2031
Human durability data, controlled studies and manufacturing consistency will indicate whether the field is progressing towards commercial use.
5 min read →07
EPI-001 hair-cloning trial (2026): status and dates
EPI-001 remains recruiting. Primary completion is estimated for June 2028 and study completion for June 2029; no clinical results are posted.
6 min read →08
HairClone’s reported clinical evaluation in Guatemala
HairClone says its GMP facility is operational and volunteers have been selected for autologous follicle-cell injections.
5 min read →09
OrganTech’s three-cell follicle-regeneration model
A 2026 study identified an accessory mesenchymal population needed for sustained follicle development in an experimental system.
6 min read →10
Hair-follicle banking: current services and future uncertainty
Banking preserves follicles for possible future use; it does not guarantee that a future cloning treatment will work or be available.
6 min read →11
Acorn’s follicle-secretome trial and its relation to hair cloning
The recruiting study uses products secreted by cultured follicle-derived cells, not implanted cells or engineered follicles.
5 min read →12
When will hair cloning be available? Trial dates and evidence
Human follicular-cell trials are under way, including EPI-001, but current evidence does not support a date for an approved, widely available hair-cloning treatment.
7 min read →13
Hair cloning cost in 2026: what is known and unknown
No approved routine hair-cloning treatment or established price exists. Future cost depends on cell manufacturing, quality control, implantation, scale and durability.
6 min read →14
Hair cloning and hair transplantation: implications for donor supply
A transplant redistributes existing resistant follicles. Follicle multiplication aims to expand the supply and remains experimental.
6 min read →